Document is current
Any future updates will be listed below
-
Authors
Salloum, Ramzi G.
Bishop, Jeffrey R.
Elchynski, Amanda L.
Smith, D. Max
Rowe, Elizabeth
Blake, Kathryn V.
Limdi, Nita A.
Aquilante, Christina L.
Bates, Jill
Beitelshees, Amber L.
Cipriani, Amber
Duong, Benjamin Q.
Empey, Philip E.
Formea, Christine M.
Hicks, J. Kevin
Mroz, Pawel
Oslin, David
Pasternak, Amy L.
Petry, Natasha
Ramsey, Laura B.
Schlichte, Allyson
Swain, Sandra M.
Ward, Kristen M.
Wiisanen, Kristin
Skaar, Todd C.
Van Driest, Sara L.
Cavallari, Larisa H.
Tuteja, Sony http://orcid.org/0000-0001-7007-3289
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (U01HG007269, U01 HG010232, U01 HG010245, U01HG007775)
National Center for Advancing Translational Sciences (UL1TR001427, U54TR001857, KL2TR002492)
National Heart, Lung, and Blood Institute (K23 HL143161, K24HL133373)
Agency for Healthcare Research and Quality (K12HS026379)
- License Information
-
More Information
Article History
Received: 23 February 2022
Accepted: 25 April 2022
First Online: 14 May 2022
Declarations
:
: The survey protocol used in this study was approved by the University of Florida Institutional Review Board.
: Not applicable.
: D.M.S. has institution-associated research funding from Kailos Genetics. P.E.E. performs consulting at Cipherome. S.M.S. has a consulting/advisory or non-promotional speaking role from Exact Sciences (Genomic Health), Genentech/Roche, Daiichi Sankyo, Athenex, Natura, and Silverback Therapeutics; IDMC from AstraZeneca; support for third party writing assistance from Genentech/Roche; and institution-associated research funding from Genentech and Kailos Genetics. L.B.R. receives research funding from BTG, Intl. The other authors declare that they have no competing interests.
